Nanjing Drum Tower Hospital ( Site 2224) — Nanjing, Jiangsu

Public research footprint of Nanjing Drum Tower Hospital ( Site 2224), compiled from the ClinicalTrials.gov public registry.

663

Registered studies

323

Active

188

Recruiting now

192

Completed

Stopped or withdrawn

Most-studied conditions

Non-Small Cell Lung Cancer (NSCLC) · Squamous Cell Carcinoma of Head and Neck · HR Low-Positive/HER2-Negative Breast Neoplasms · Metastatic Castration Sensitive Prostate Cancer (mCSPC)

Recently updated registry entries

NCT07438496 — A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus (Recruiting)
NCT06919965 — A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants… (Recruiting)
NCT06772623 — Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Nanjing Drum Tower Hospital ( Site 2224)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.